Stay updated on AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Sign up to get notified when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.

Latest updates to the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a detailed description of a Phase 2 study for AV-101 in Parkinson's Disease, which included inclusion and exclusion criteria for participants. Additionally, a new version number has been introduced.SummaryDifference39%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to AV-101 for Levodopa Dyskinesia: PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AV-101 for Levodopa Dyskinesia: PD Clinical Trial page.